agilon health (NYSE:AGL) Earns Market Perform Rating from Analysts at Sanford C. Bernstein

Stock analysts at Sanford C. Bernstein assumed coverage on shares of agilon health (NYSE:AGL) in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. The firm set a “market perform” rating and a $2.50 price target on the stock. Sanford C. Bernstein’s target price would suggest a potential upside of 12.11% from the stock’s current price.

Other equities analysts also recently issued research reports about the company. TD Cowen dropped their price target on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday, November 11th. William Blair cut agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price on the stock. in a report on Wednesday, October 2nd. Barclays lowered their price target on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a report on Monday, November 11th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $3.00 price objective on shares of agilon health in a research note on Tuesday, November 19th. Three research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $4.38.

agilon health Trading Up 12.1 %

NYSE:AGL opened at $2.23 on Wednesday. The company has a market capitalization of $918.80 million, a PE ratio of -2.37 and a beta of 0.51. agilon health has a 52-week low of $1.50 and a 52-week high of $13.76. The stock has a fifty day simple moving average of $2.46 and a 200-day simple moving average of $4.42. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. During the same period last year, the company earned ($0.06) EPS. On average, equities research analysts expect that agilon health will post -0.5 earnings per share for the current fiscal year.

Insider Transactions at agilon health

In related news, Director Diana Mckenzie bought 12,500 shares of the stock in a transaction dated Monday, November 25th. The stock was acquired at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the completion of the purchase, the director now owns 51,319 shares in the company, valued at $117,007.32. This represents a 32.20 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John William Wulf bought 45,000 shares of the company’s stock in a transaction that occurred on Thursday, December 5th. The shares were bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the acquisition, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 65,000 shares of company stock worth $143,100 in the last three months. 3.20% of the stock is currently owned by company insiders.

Institutional Trading of agilon health

Large investors have recently bought and sold shares of the company. J.Safra Asset Management Corp boosted its stake in shares of agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of agilon health during the third quarter valued at about $28,000. City State Bank acquired a new stake in shares of agilon health during the third quarter valued at about $52,000. CWM LLC increased its position in shares of agilon health by 406.5% during the second quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after acquiring an additional 7,288 shares during the last quarter. Finally, Nisa Investment Advisors LLC acquired a new position in shares of agilon health in the second quarter worth about $60,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.